Off-label promotions getting riskier for pharmas; FDA scientists claim retaliation by superiors;

> Could the climate be getting hotter for pharmas that try to sneak in off-label promotions of medications? FiercePharma

> A group of FDA scientists who complained to President Obama's team about corruption at the agency may have been placed under criminal investigation by the agency, the scientists now say. FiercePharma

Healthcare mergers and acquisitions should continue throughout this year, but only by buyers who have cash and are ready to implement cost-cutting strategies, according to panelists at a recent healthcare M&A conference. FierceHealthFinance

> A team of researchers has concluded that a cold virus, of all things, may have a role in the development of obesity. FierceBioResearcher

And Finally... The lesson here: Don't do anything illegal that can be seen by a satellite. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.